DNA
Ginkgo Bioworks Holdings, Inc.Healthcare$6.90
▲ Bullish
Mkt Cap: $427.3M|Float: 41.7M|SI: 19.2%|DTC: 6.6
Data as of market close Apr 2, 2026
IV Rank
32
IV Pctl
44%
HV 20d
10075.0%
52W Range
$5-$18
ATR(14)
$0.53
Exp. Move
±15.2%
P/C Ratio
0.43
Earnings
May 5
GEX Positive
DEX Long
Net Call Premium
IV Moderate
Max Pain Above
Exp. Move Wide
Low Put/Call
DNA Key Options Data
- IV Rank
- 32.4%
- Total GEX
- $0.00B
- Total DEX
- $0.3M
- Max Pain
- $7.00
- Expected Move
- ±15.2%
- Put/Call OI
- 0.43
- Net Premium
- $0.0M
- Spot Price
- $6.90
Gamma Exposure (GEX)
Delta Exposure (DEX)
Expected Move by Expiration
| Expiration | DTE | Expected Move | Move % | Lower | Upper |
|---|---|---|---|---|---|
| 2026-04-17 | 15 | ±$1.05 | ±15.2% | $5.85 | $7.95 |
| 2026-05-15 | 43 | ±$0.88 | ±12.7% | $6.03 | $7.78 |
| 2026-06-18 | 77 | ±$2.73 | ±39.5% | $4.18 | $9.63 |
| 2026-09-18 | 169 | ±$4.05 | ±58.7% | $2.85 | $10.95 |
| 2027-01-15 | 288 | ±$3.92 | ±56.9% | $2.98 | $10.83 |
Explore DNA options data including implied volatility rankings, gamma and delta exposure, max pain levels, and expected price moves. AI-generated reports provide directional, income, and earnings analysis.